Seres Therapeutics MCRB
NASDAQ MCRB
$2.12 -0.18 (-7.84%)
As of: Oct 22, 2026 · 2:25 PM EDT

Seres Therapeutics (MCRB) EV to FCF (2016 - 2025)

Updated

Seres Therapeutics' EV to FCF was 111.48 in Q4 2025.

Analysis

Seres Therapeutics (MCRB) EV to FCF (2016 - 2025) Analysis & Trends

From Q1 2016 onward, Seres Therapeutics has reported EV to FCF for 6 quarters.

  • The Q4 2025 figure marks the lowest quarterly EV to FCF since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn
10 Seres Therapeutics 20.58 Mn -118.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 111.48
Sep 30, 2021 9.00
Dec 31, 2016 7.56
Sep 30, 2016 8.10
Jun 30, 2016 23.31
Mar 31, 2016 12.03
API Access

Seres Therapeutics EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=MCRB&period=max&api_key=YOUR_API_KEY